Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OPTR > SEC Filings for OPTR > Form 8-K on 9-May-2013All Recent SEC Filings

Show all filings for OPTIMER PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for OPTIMER PHARMACEUTICALS INC


9-May-2013

Results of Operations and Financial Condition, Submission of Matters


Item 2.02. Results of Operations and Financial Condition.

On May 9, 2013, Optimer Pharmaceuticals, Inc. (the "Company") issued a press release announcing its unaudited financial results for the quarter ended March 31, 2013. A copy of this press release is attached hereto as Exhibit 99.1.

This information included in this Item 2.02 and the exhibit hereto are being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.



Item 5.07. Submission of Matters to a Vote of Security Holders.

Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2013 Annual Meeting of Stockholders held on May 8, 2013.

Proposal 1 - Election of Directors



The following directors were elected to serve for three-year terms until the
2016 Annual Meeting of Stockholders and until their respective successors are
elected and qualified.



                          Number of Shares   Number of Shares Voted
Director Elected             Voted For        Against or Withheld     Broker Non-Vote
Mark Auerbach                19,262,253            13,698,181            8,257,346
Joseph Y. Chang, Ph.D.       19,091,714            13,868,720            8,257,346
Stephen L. Newman, M.D.      19,394,551            13,565,883            8,257,346

Proposal 2 - Ratification of the appointment of Ernst and Young, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013.

For Against Abstain Broker Non-Vote 40,747,036 314,193 156,551 0

Proposal 3 - Approval, on and advisory basis, of the compensation of our named executive officers.

For Against Abstain Broker Non-Vote 23,286,590 9,531,904 141,940 8,257,346



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated May 9, 2013.


  Add OPTR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OPTR - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.